Details of the Drug
General Information of Drug (ID: DMS7WQD)
Drug Name |
2-(ethoxycarbonyl)-1H-indole-5-carboxylic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(ethoxycarbonyl)-1H-indole-5-carboxylic acid; 138731-14-3; 2-(ethoxycarbonyl)indole-5-carboxylic acid; 1H-INDOLE-2,5-DICARBOXYLIC ACID 2-ETHYL ESTER; CHEMBL503643; CAVYPAYXEMVXMS-UHFFFAOYSA-N; 2-ETHOXYCABONYL-5-INDOLE CARBOXYLIC ACID; 2-ethoxycarbonyl-1H-indole-5-carboxylic acid; SCHEMBL1306748; AC1Q34A5; CTK6F6093; DTXSID70592508; MolPort-004-323-750; KS-00000BY1; STK695496; SBB019411; 1264AJ; ZINC14985904; BDBM50268451; AKOS000161198; MCULE-3298585220; AB49136; NCGC00341253-01; BS-14093; SY043081; AJ-66467
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 233.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||